FR2373287A1 - Nouvelle association de principes actifs de medicaments pour maitriser de facon selective les reactions immunitaires induites chez un hote par l'administration d'antigenes - Google Patents

Nouvelle association de principes actifs de medicaments pour maitriser de facon selective les reactions immunitaires induites chez un hote par l'administration d'antigenes

Info

Publication number
FR2373287A1
FR2373287A1 FR7735899A FR7735899A FR2373287A1 FR 2373287 A1 FR2373287 A1 FR 2373287A1 FR 7735899 A FR7735899 A FR 7735899A FR 7735899 A FR7735899 A FR 7735899A FR 2373287 A1 FR2373287 A1 FR 2373287A1
Authority
FR
France
Prior art keywords
administration
host
antigens
immune reactions
active drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7735899A
Other languages
English (en)
Other versions
FR2373287B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB49826/76A external-priority patent/GB1600119A/en
Application filed by Individual filed Critical Individual
Publication of FR2373287A1 publication Critical patent/FR2373287A1/fr
Application granted granted Critical
Publication of FR2373287B1 publication Critical patent/FR2373287B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nouvelle association de médicaments. Elle comprend des constituants capables simultanément de bloquer les récepteurs alpha-adrénergiques des cellules pour les catécholamines, les récepteurs dopaminergiques des cellules et d'accroître la synthèse de la sérotonine. Une composition préférée contient de la phentolamine, de l'halopéridol et du L-5-hydroxytryptophane. Application en tant que médicament pour maîtriser de façon sélective les réaction immunitaires induites chez un hôte par l'administration d'antigènes déterminés.
FR7735899A 1976-11-30 1977-11-29 Nouvelle association de principes actifs de medicaments pour maitriser de facon selective les reactions immunitaires induites chez un hote par l'administration d'antigenes Granted FR2373287A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB49826/76A GB1600119A (en) 1976-11-30 1976-11-30 Combination of drugs for the selective control of the immune reactions evoked in a host by the administration of antigens
GB2681777 1977-06-27

Publications (2)

Publication Number Publication Date
FR2373287A1 true FR2373287A1 (fr) 1978-07-07
FR2373287B1 FR2373287B1 (fr) 1980-08-22

Family

ID=26258445

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7735899A Granted FR2373287A1 (fr) 1976-11-30 1977-11-29 Nouvelle association de principes actifs de medicaments pour maitriser de facon selective les reactions immunitaires induites chez un hote par l'administration d'antigenes

Country Status (8)

Country Link
US (1) US4310535A (fr)
JP (1) JPS5396333A (fr)
CA (1) CA1098829A (fr)
DE (1) DE2753394A1 (fr)
FR (1) FR2373287A1 (fr)
IL (1) IL53452A (fr)
IT (1) IT1092158B (fr)
NL (1) NL7713244A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070084A (en) * 1990-02-26 1991-12-03 Campbell James N Treatment of sympathetically maintained pain
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
US5447947A (en) * 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
DK1280531T3 (da) * 2000-05-12 2007-05-29 Novalar Pharmaceuticals Inc Formulering bestående af phentolaminmesylat og anvendelse heraf
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US9616123B1 (en) * 2012-03-05 2017-04-11 Robert L. Knobler Method and compound for treatment of menopausal symptoms

Also Published As

Publication number Publication date
IL53452A0 (en) 1978-01-31
FR2373287B1 (fr) 1980-08-22
IL53452A (en) 1980-12-31
NL7713244A (nl) 1978-06-01
JPS5396333A (en) 1978-08-23
US4310535A (en) 1982-01-12
DE2753394A1 (de) 1978-06-01
CA1098829A (fr) 1981-04-07
IT1092158B (it) 1985-07-06

Similar Documents

Publication Publication Date Title
KR850004392A (ko) 경구투여용 장기작용 약제의 제조방법 및 조성물
NO171145C (no) Fremgangsmaate for fremstilling av en fettemulsjon med et hydrofobt medikament
SE8402551L (sv) Cinnamoylmoranolin-derivat
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
ES321779A1 (es) Un metodo para elaborar composiciones farmaceuticas.
KR970025615A (ko) 암 전이 억제제
FR2373287A1 (fr) Nouvelle association de principes actifs de medicaments pour maitriser de facon selective les reactions immunitaires induites chez un hote par l'administration d'antigenes
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
CO4230093A1 (es) Derivados del indol y sus usos medicos
KR880007060A (ko) 제약 조성물
OA07029A (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux.
KR890004705A (ko) 항바이러스성 제제
KR900012925A (ko) 인돌 유도체
KR880701102A (ko) 주석 디요오도 듀테로 포르피린의 치료용도
KR830009776A (ko) 세포 보호 유도방법
US3873709A (en) Method of treating psychosis
WILKINS et al. Serotonin and Antiserotonins: II. Clinical Studies, Especially in Essential Hypertension with the Benzyl Analog of Serotonin (BAS)
JPH07505128A (ja) 局所投与用薬学的組成物の調整の為の公知化合物の使用
US3137625A (en) Diuretic combinations containing a thiazide and a mercurial
SIMPSON et al. Fatal aplastic anemia occurring during anticonvulsant therapy: probable idiosyncrasy to phenurone
Gear, JHS,**** Yeo, RM**** & Bodenstein The aetiology of onyalai
SU263807A1 (ru) Новый способ лечени анемии и озены
FR2356652A1 (fr) Nouvelles penicillines et medicaments contenant ces substances
KR880013556A (ko) 도파민수용체 효능제의 용도
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제

Legal Events

Date Code Title Description
ST Notification of lapse